Bigul

SMS Pharmaceuticals Ltd - 532815 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On 12.11.2021

SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve NOTICE is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013 that a meeting of the Board of Directors of the Company will be held on the Friday, 12th day of November, 2021, at the Registered Office of the Company, inter alia, for the following items: To consider and approve the Un-audited Standalone and Consolidated Financial results of the Company for the Quarter and half year ended as on 30th September, 2021. Please be informed that Insider Trading window of SMS Pharmaceuticals Limited shall remain closed till 14th November, 2021 in view of the above mentioned Board Meeting.
06-11-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Intimation For Loss Of Share Certificates As Per Regulation 39(3) Of The SEBI(LODR) Regulations, 2015.

Pursuant to Regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that the share certificates as per details given below are reported to have been lost / misplaced and request from shareholder is received by the Company through its Registrar and Share Transfer Agent M/s Aarthi consultants Private Limited for issue of duplicate share certificate(s) in lieu thereof.
05-11-2021
Bigul

SMS Pharmaceuticals Ltd - 532815 - Rejection Of Request For Issue Of Duplicate Share Certificates - Non Receipt Of Required Documents. Re; Regulation 39(3) Of SEBI (LODR) Regulations, 2015.

We submit that the Company had intimated on 06-10-2021 about the receipt of letter from the following shareholder regarding loss of share certificates with request for issue of duplicate share certificates in lieu thereof.
29-10-2021
Bigul

SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a herewith a copy of investor presentation of the Company.
28-10-2021
Bigul

SMS Pharmaceuticals Ltd - 532815 - Reclassification Of Promoters ( Application Submitted)

In-furtherance to aforementioned intimations, we would like to inform your esteemed office that the Company has submitted on application to stock Exchanges (S) today (i.e. 27th October, 2021), for reclassification of the following promoters from 'Promoter Group' category to 'Public' Category. Pursuant to Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
27-10-2021
Bigul

SMS Pharmaceuticals Ltd - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate dated 6th October, 2021, received from Aarthi Consultants Private Limited, Hyderabad, the Registrar and Share Transfer Agent of the Company for the quarter ended 30th September, 2021.
11-10-2021
Bigul

SMS Pharmaceuticals Ltd - 532815 - Statement Of Investor Complaints For The Quarter Ended September 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- V S VenkatishDesignation :- Company Secretary and Compliance Officer
08-10-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Shareholding for the Period Ended September 30, 2021

SMS Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
08-10-2021
Bigul

SMS Pharmaceuticals Ltd - 532815 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that the share certificates as per details given below are reported to have been lost / misplaced and request from shareholder is received by the Company through its Registrar and Share Transfer Agent M/s Aarthi consultants Private Limited for issue of duplicate share certificate(s) in lieu thereof.
06-10-2021
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

SMS Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
04-10-2021
Next Page
Close

Let's Open Free Demat Account